CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 120 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,754 | -25.3% | 49,421 | -0.4% | 0.04% | -26.5% |
| Q2 2023 | $85,306 | +113.9% | 49,596 | +87.8% | 0.05% | +133.3% |
| Q1 2023 | $39,884 | +0.6% | 26,412 | +6.6% | 0.02% | 0.0% |
| Q4 2022 | $39,660 | -44.1% | 24,787 | -48.2% | 0.02% | -44.7% |
| Q3 2022 | $71,000 | +6.0% | 47,869 | +33.3% | 0.04% | +18.8% |
| Q2 2022 | $67,000 | +67.5% | 35,919 | +145.3% | 0.03% | +113.3% |
| Q1 2022 | $40,000 | -35.5% | 14,644 | +6.5% | 0.02% | -28.6% |
| Q4 2021 | $62,000 | -8.8% | 13,744 | +2.6% | 0.02% | -16.0% |
| Q3 2021 | $68,000 | – | 13,394 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |